{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T00:19:09Z","timestamp":1769127549200,"version":"3.49.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,9,24]]},"DOI":"10.7759\/cureus.10627","type":"journal-article","created":{"date-parts":[[2020,9,24]],"date-time":"2020-09-24T08:35:21Z","timestamp":1600936521000},"source":"Crossref","is-referenced-by-count":7,"title":["All-Cause Mortality Outcomes of Usage of Cardiac Contractility Modulation in Patients With Dilated Cardiomyopathy Ineligible for Cardiac Re-Synchronization Therapy: An Updated Meta-Analysis of Randomized Controlled Trials"],"prefix":"10.7759","author":[{"given":"Muhammad","family":"Nadeem","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ezza Fatima","family":"Tariq","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hafiz M","family":"Aslam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasir","family":"Illahi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rehan","family":"Shah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2013.05.019","article-title":"2013 ACCF\/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines","volume":"62","author":"Yancy CW","year":"2013","unstructured":"Yancy CW, Jessup M, Bozkurt B, et al.. 2013 ACCF\/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2013, 62:147-239. 10.1016\/j.jacc.2013.05.019","journal-title":"J Am Coll Cardiol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.med.57.051804.122251","article-title":"Cardiac resynchronization treatment of heart failure","volume":"58","author":"Hasan A","year":"2007","unstructured":"Hasan A, Abraham WT. Cardiac resynchronization treatment of heart failure. Annu Rev Med. 2007, 58:63-74. 10.1146\/annurev.med.57.051804.122251","journal-title":"Annu Rev Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2003.09.053","article-title":"Prevalence of QRS prolongation in a community hospital cohort of patients with heart failure and its relation to left ventricular systolic dysfunction","volume":"93","author":"Sandhu R","year":"2004","unstructured":"Sandhu R, Bahler RC. Prevalence of QRS prolongation in a community hospital cohort of patients with heart failure and its relation to left ventricular systolic dysfunction. Am J Cardiol. 2004, 93:244-246. 10.1016\/j.amjcard.2003.09.053","journal-title":"Am J Cardiol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2005.03.078","article-title":"Management of heart failure after cardiac resynchronization therapy: integrating advanced heart failure treatment with optimal device function","volume":"46","author":"Aranda JMJ","year":"2005","unstructured":"Aranda JMJ, Woo GW, Schofield RS, et al.. Management of heart failure after cardiac resynchronization therapy: integrating advanced heart failure treatment with optimal device function. J Am Coll Cardiol. 2005, 46:2193-2198. 10.1016\/j.jacc.2005.03.078","journal-title":"J Am Coll Cardiol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.01311.2004","article-title":"Nonexcitatory electrical signals for enhancing ventricular contractility: rationale and initial investigations of an experimental treatment for heart failure","volume":"288","author":"Burkhoff D","year":"2005","unstructured":"Burkhoff D, Ben-Haim SA. Nonexcitatory electrical signals for enhancing ventricular contractility: rationale and initial investigations of an experimental treatment for heart failure. Am J Physiol Heart Circ Physiol. 2005, 288:2550-2556. 10.1152\/ajpheart.01311.2004","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2005.05.093","article-title":"Electrical signals applied during the absolute refractory period: an investigational treatment for advanced heart failure in patients with normal QRS duration","volume":"46","author":"Lawo T","year":"2005","unstructured":"Lawo T, Borggrefe M, Butter C, et al.. Electrical signals applied during the absolute refractory period: an investigational treatment for advanced heart failure in patients with normal QRS duration. J Am Coll Cardiol. 2005, 46:2229-2236. 10.1016\/j.jacc.2005.05.093","journal-title":"J Am Coll Cardiol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejheart.2003.11.001","article-title":"Long-term effects of non-excitatory cardiac contractility modulation electric signals on the progression of heart failure in dogs","volume":"6","author":"Morita H","year":"2004","unstructured":"Morita H, Suzuki G, Haddad W, et al.. Long-term effects of non-excitatory cardiac contractility modulation electric signals on the progression of heart failure in dogs. Eur J Heart Fail. 2004, 6:145-150. 10.1016\/j.ejheart.2003.11.001","journal-title":"Eur J Heart Fail"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2006.10.082","article-title":"Therapy with cardiac contractility modulation electrical signals improves left ventricular function and remodeling in dogs with chronic heart failure","volume":"49","author":"Imai M","year":"2007","unstructured":"Imai M, Rastogi S, Gupta RC, et al.. Therapy with cardiac contractility modulation electrical signals improves left ventricular function and remodeling in dogs with chronic heart failure. J Am Coll Cardiol. 2007, 49:2120-2128. 10.1016\/j.jacc.2006.10.082","journal-title":"J Am Coll Cardiol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2008.01.036","article-title":"Cardiac contractility modulation electrical signals improve myocardial gene expression in patients with heart failure","volume":"51","author":"Butter C","year":"2008","unstructured":"Butter C, Rastogi S, Minden HH, Meyh\u00f6fer J, Burkhoff D, Sabbah HN. Cardiac contractility modulation electrical signals improve myocardial gene expression in patients with heart failure. J Am Coll Cardiol. 2008, 51:1784-1789. 10.1016\/j.jacc.2008.01.036","journal-title":"J Am Coll Cardiol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1111\/j.1752-8062.2009.00097.x","article-title":"Ca(2+)-binding proteins in dogs with heart failure: effects of cardiac contractility modulation electrical signals","volume":"2","author":"Gupta RC","year":"2009","unstructured":"Gupta RC, Mishra S, Rastogi S, et al.. Ca(2+)-binding proteins in dogs with heart failure: effects of cardiac contractility modulation electrical signals. Clin Transl Sci. 2009, 2:211-215. 10.1111\/j.1752-8062.2009.00097.x","journal-title":"Clin Transl Sci"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchf.2018.04.010","article-title":"A randomized controlled trial to evaluate the safety and efficacy of cardiac contractility modulation","volume":"6","author":"Abraham WT","year":"2018","unstructured":"Abraham WT, Kuck KH, Goldsmith RL, et al.. A randomized controlled trial to evaluate the safety and efficacy of cardiac contractility modulation. JACC Heart Fail. 2018, 6:874-883. 10.1016\/j.jchf.2018.04.010","journal-title":"JACC Heart Fail"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehn020","article-title":"Randomized, double blind study of non-excitatory, cardiac contractility modulation electrical impulses for symptomatic heart failure","volume":"29","author":"Borggrefe MM","year":"2008","unstructured":"Borggrefe MM, Lawo T, Butter C, et al.. Randomized, double blind study of non-excitatory, cardiac contractility modulation electrical impulses for symptomatic heart failure. Eur Heart J. 2008, 29:1019-1028. 10.1093\/eurheartj\/ehn020","journal-title":"Eur Heart J"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.hrthm.2006.06.031","article-title":"Nonexcitatory, cardiac contractility modulation electrical impulses: feasibility study for advanced heart failure in patients with normal QRS duration","volume":"3","author":"Neelagaru SB","year":"2006","unstructured":"Neelagaru SB, Sanchez JE, Lau SK, et al.. Nonexcitatory, cardiac contractility modulation electrical impulses: feasibility study for advanced heart failure in patients with normal QRS duration. Heart Rhythm. 2006, 3:1140-1147. 10.1016\/j.hrthm.2006.06.031","journal-title":"Heart Rhythm"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2010.10.025","article-title":"A randomized controlled trial evaluating the safety and efficacy of cardiac contractility modulation in advanced heart failure","volume":"161","author":"Kadish A","year":"2011","unstructured":"Kadish A, Nademanee K, Volosin K, et al.. A randomized controlled trial evaluating the safety and efficacy of cardiac contractility modulation in advanced heart failure. Am Heart J. 2011, 161:329-337. 10.1016\/j.ahj.2010.10.025","journal-title":"Am Heart J"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-151-4-200908180-00135","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"151","author":"Moher D","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG; PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med. 2009, 151:264-269. 10.7326\/0003-4819-151-4-200908180-00135","journal-title":"Ann Intern Med"},{"key":"ref16","article-title":"Cochrane Handbook for Systematic Reviews of Interventions version 6.0 (updated July 2019)","year":"2019","unstructured":"Cochrane Handbook for Systematic Reviews of Interventions version 6.0 (updated July 2019). Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA (ed). Cochrane, 2019."},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1007\/s00059-016-4514-5","article-title":"The safety and efficacy of cardiac contractility modulation in heart failure: a meta-analysis of clinical trials","volume":"42","author":"Liu X","year":"2017","unstructured":"Liu X, Yang HJ, Ping HQ, Qiu S, Shi S, Yang B. The safety and efficacy of cardiac contractility modulation in heart failure: a meta-analysis of clinical trials. Herz. 2017, 42:766-775. 10.1007\/s00059-016-4514-5","journal-title":"Herz"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200103223441202","article-title":"Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay","volume":"344","author":"Cazeau S","year":"2001","unstructured":"Cazeau S, Leclercq C, Lavergne T, et al.. Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay. N Engl J Med. 2001, 344:873-880. 10.1056\/NEJM200103223441202","journal-title":"N Engl J Med"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1001\/jama.289.20.2685","article-title":"Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure: the MIRACLE ICD Trial","volume":"289","author":"Young JB","year":"2003","unstructured":"Young JB, Abraham WT, Smith AL, et al.. Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure: the MIRACLE ICD Trial. JAMA. 2003, 289:2685-2694. 10.1001\/jama.289.20.2685","journal-title":"JAMA"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/s0735-1097(03)01042-8","article-title":"Cardiac resynchronization therapy for the treatment of heart failure in patients with intraventricular conduction delay and malignant ventricular tachyarrhythmias","volume":"42","author":"Higgins SL","year":"2003","unstructured":"Higgins SL, Hummel JD, Niazi IK, et al.. Cardiac resynchronization therapy for the treatment of heart failure in patients with intraventricular conduction delay and malignant ventricular tachyarrhythmias. J Am Coll Cardiol. 2003, 42:1454-1459. 10.1016\/s0735-1097(03)01042-8","journal-title":"J Am Coll Cardiol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/21879-all-cause-mortality-outcomes-of-usage-of-cardiac-contractility-modulation-in-patients-with-dilated-cardiomyopathy-ineligible-for-cardiac-re-synchronization-therapy-an-updated-meta-analysis-of-randomized-controlled-trials","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:23:43Z","timestamp":1707506623000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/21879-all-cause-mortality-outcomes-of-usage-of-cardiac-contractility-modulation-in-patients-with-dilated-cardiomyopathy-ineligible-for-cardiac-re-synchronization-therapy-an-updated-meta-analysis-of-randomized-controlled-trials"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,24]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.10627","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9,24]]}}}